Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3

Mitchell L. Shiffman, Fredy Suter, Bruce R. Bacon, David Nelson, Hugh Harley, Ricard Solá, Stephen D. Shafran, Karl Barange, Amy Lin, Ash Soman, Stefan Zeuzem

Research output: Contribution to journalArticleResearchpeer-review

514 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology

Nursing and Health Professions